Homocysteine and CAD

NEW YORK, June 27 (Praxis Press) Circulating homocysteine levels can be used to predict survival in patients with stable coronary artery disease. The prognostic value of serum homocysteine levels, obtained in the acute phase in patients with myocardial infarction or unstable angina, however, is unknown. To test this hypothesis, Omland and colleagues measured the serum homocysteine levels of a total of 579 patients with Q-wave myocardial infarction (n=163), non- Q-wave myocardial infarction (n=21

June 27, 2000

NEW YORK, June 27 (Praxis Press) Circulating homocysteine levels can be used to predict survival in patients with stable coronary artery disease. The prognostic value of serum homocysteine levels, obtained in the acute phase in patients with myocardial infarction or unstable angina, however, is unknown. To test this hypothesis, Omland and colleagues measured the serum homocysteine levels of a total of 579 patients with Q-wave myocardial infarction (n=163), non- Q-wave myocardial infarction (n=210 patients), and unstable angina pectoris (n=206) (see paper). They then examined all-cause mortality after 628 days and found that 65 patients died. Serum homocysteine level was significantly lower in long-term survivors compared with nonsurvivors. The serum homocysteine level on hospital admission is an independent predictor of long-term survival in patients with acute coronary syndromes.

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Inflammation Drives Gut Bacteria Evolution
  4. Opinion: On “The Impact Factor Fallacy”
Business Birmingham